ONCY
Oncolytics Biotech Inc
0.5969$
-5.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.9% | +15.0% | -20.3% | +7.1% | -48.4% | -64.9% | +534.7% | -46.5% | -307.9% | – | -6.3% | – | |
| – | +1.2% | -24.1% | -12.2% | -12.1% | +72.4% | +10.2% | -50.3% | +599.4% | -137.4% | – | -61.7% | – | |
| – | -58.5% | -102.2% | – | +1,907.4% | -120.0% | – | – | – | -95.2% | -1,422.7% | – | – | |
| – | +24,900.0% | +1,433.3% | +237.0% | -79.4% | -96.0% | -22.8% | +0.0% | +465.5% | -82.8% | +518.6% | -99.6% | – | |
| – | -100.0% | +1,433.3% | +237.0% | -79.4% | – | -116.9% | – | -602.9% | -74.5% | +367.3% | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +25.0% | +3.0% | -1.0% | -1.0% | – | – | – | – | |
| – | -91.8% | -14.2% | +32.1% | -108.8% | – | +41.6% | +38.7% | -25.0% | -17.7% | +112.7% | -12.0% | – | |
| – | -122.6% | – | – | – | – | -167.9% | – | -2,578.9% | – | – | -573.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.